Issi Rozen is chief business officer at the Broad Institute and an expert in structuring life sciences partnerships, in/out-licensing transactions, and the formation and establishment of new ventures. Before joining the Broad Institute, Mr. Rozen led corporate development efforts at Resolvyx Pharmaceuticals, a venture-backed biotech start-up. Prior to that, he led the business analysis group at EMD Serono, where he was responsible for evaluating in-licensing and M&A opportunities as well as commercial analytics and forecasting. He is also a co-founder of a number of Boston-based biotech start-ups and is an accomplished jazz guitarist. He earned his MBA at MIT’s Sloan School of Management.